Skip to main content

Search articles in

Found 3,311 articles

  • Envision Pharma Group launches 4Sight to drive AI

    Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare

    • 19 Jul 2024
    • Editor

    Leading global technology solutions partner Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimize raw data and turn it into actionable insights for healthcare professionals.

  • Danaher Announces Two New Centers of Innovation in

    Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development

    • 18 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced the launch of two new Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified labs intended to accelerate the development of Companion Diagnostics (CDx) and Complementary Diagnostics (CoDx).

  • Chief Medical Officer Merdad Parsey to Leave Gilea

    Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025

    • 18 Jul 2024
    • Editor

    Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Chief Medical Officer Merdad Parsey, MD, PhD, will leave the company early next year. While the company works to identify a successor, Dr. Parsey will continue as Chief Medical Officer until the first quarter of 2025 and support this transition over the next several months.

  • The Impact of AI on Pharmaceutical R&D and Drug Di

    The Impact of AI on Pharmaceutical R&D and Drug Discovery

    • 17 Jul 2024
    • Lucy Walters

    The future of drug discovery and pharmaceutical research and development is being reshaped by artificial intelligence (AI), heralding a new era of speed, efficiency, and precision. AI’s potential to accelerate drug development, from molecular prediction to optimised design and improved clinical trials, promises to significantly cut costs and time-to-market for new medications.

  • About ALZpath

    About ALZpath

    • 17 Jul 2024
    • Editor

    ALZpath is a leading developer of innovative diagnostic tools and solutions for Alzheimer’s disease and related dementias. The novel ALZpath pTau217 antibody, integral to the most advanced, widely available blood-based tests to detect Alzheimer’s disease, is transforming its diagnosis and treatment monitoring, providing accurate and accessible tools for researchers and healthcare professionals worldwide.

  • Nouscom Appoints Tiffany Muller as Chief Financial

    Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development

    • 17 Jul 2024
    • Editor

    Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today announces the promotion of Tiffany Muller to Chief Financial Officer (CFO) and Loredana Siani, Ph.D., to Senior Vice President (SVP), Technical and CMC Development.

  • For third consecutive year, Stryker named 2024 Bes

    For third consecutive year, Stryker named 2024 Best Place to Work for Disability Inclusion

    • 17 Jul 2024
    • Editor

    Stryker has been once again named a top-scoring business on the Disability Equality Index® (DEI) by the nation’s largest disability rights organization, the American Association of People with Disabilities, and Disability:IN, the global business disability inclusion network, for our efforts to advance inclusion for people with disabilities.

  • Insider's Guide to Hiring a Scientist

    Insider's Guide to Hiring a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • Step by Step Guide to Hiring a Scientist

    Step by Step Guide to Hiring a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • How to Hire a Scientist

    How to Hire a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • About CNX Therapeutics

    About CNX Therapeutics

    • 16 Jul 2024
    • Editor

    CNX Therapeutics is a speciality pharmaceutical company committed to improving the lives of patients by providing access to essential medicines. CNX commercialises and distributes a portfolio of pharmaceuticals for neurological, psychiatric and hospital emergencies in over 40 countries worldwide, both directly and through strategic partnerships.

  • Stryker completes acquisition of Artelon, Inc.

    Stryker completes acquisition of Artelon, Inc.

    • 16 Jul 2024
    • Editor

    Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.

  • Anacura

    Anacura

    • 15 Jul 2024
    • Editor

    Anacura is an independent laboratory group with more than 250 dynamic employees based in Evergem (Ghent) and Bruges. Active in various areas of healthcare, anacura is known for its customer-centric support. Anacura’s daughter companies AnaBioTec and Labo Nuytinck deliver end-to-end analytical drug development solutions for pharma and biotech clients, and affordable, high-quality lab services for patients and healthcare providers, respectively.

  • Acquisition of Amolyt Pharma completed

    Acquisition of Amolyt Pharma completed

    • 15 Jul 2024
    • Editor

    AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases.

  • About HUTCHMED

    About HUTCHMED

    • 12 Jul 2024
    • Editor

    HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.

  • Danaher Launches Beacon Research Collaboration wit

    Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

    • 12 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR), a global science and technology innovator, today launched a research collaboration with Stanford University's Department of Bioengineering intended to shape the future of cancer drug screening through "smart microscopy."

  • Thermo Fisher Scientific to Help Advance Myeloid C

    Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology

    • 12 Jul 2024
    • Editor

    To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

  • Labcorp and Naples Comprehensive Healthcare Announ

    Labcorp and Naples Comprehensive Healthcare Announce Strategic Agreement for Lab Operations

    • 12 Jul 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into a comprehensive strategic collaboration with Naples Comprehensive Healthcare (NCH) in Southwest Florida to manage the daily operations of NCH’s inpatient lab operations. Separately, Labcorp will begin to serve as the primary lab for NCH’s physician network later this summer.

  • IQVIA Named a Leader in Medical Affairs and Regula

    IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group

    • 12 Jul 2024
    • Editor

    IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiveness.

  • What Does a Bioinformatician Do?

    What Does a Bioinformatician Do?

    • 11 Jul 2024
    • Lucy Walters

    Bioinformatics is an interdisciplinary field that integrates computer science, mathematics, statistics, and biology to manage and analyse biological data. This field is crucial to the life sciences industry for its role in understanding complex biological processes, leading to significant advances in drug discovery, genetic research, and personalised medicine.